Carlos Lastra
Neurology with Special Qualifications in Child Neurology · New Brunswick, NJNPI 1144249137
Payments from drug & device makers
What this record shows
18 manufacturers reported payments, led by UCB SA at 30.8% of the total. Reporting peaked in 2019 at $1,912 and has fallen 81.8% since, to $347 in 2025. Among neurology with special qualifications in child neurology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 51 payments — averaging $93.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB SA$1K
- H. Lundbeck A S$1K
- Jazz Pharmaceuticals Inc.$600
- Neurelis, Inc.$340
- Greenwich Biosciences, Inc.$217
- UCB, Inc.$140
- plus $664 from 12 others
Across 177 payments — averaging $2811.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Teva Pharmaceuticals USA, Inc.$110K
- Aquestive Therapeutics, Inc.$82K
- UCB SA$82K
- Jazz Pharmaceuticals Inc.$75K
- SK Life Science, Inc.$53K
- Takeda Pharmaceuticals U.S.A., Inc.$46K
- plus $49K from 3 others
What the payments were for
- Travel & lodging$2,51253%
- Food & beverage$2,23647%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB SA | 11 | $1,461 |
| H. Lundbeck A S | 3 | $1,327 |
| Jazz Pharmaceuticals Inc. | 7 | $600 |
| Neurelis, Inc. | 4 | $340 |
| Greenwich Biosciences, Inc. | 3 | $217 |
| UCB, Inc. | 3 | $140 |
| Catalyst Pharmaceuticals, Inc. | 1 | $121 |
| SK Life Science, Inc. | 2 | $119 |
| PTC Therapeutics, Inc. | 1 | $106 |
| Sunovion Pharmaceuticals Inc. | 1 | $79 |
| Mallinckrodt Enterprises LLC | 4 | $57 |
| Livanova USA, Inc. | 1 | $47 |
| Eisai Inc. | 3 | $41 |
| Tris Pharma Inc | 2 | $27 |
| Supernus Pharmaceuticals, Inc. | 2 | $27 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 1 | $15 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
| Novartis | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,749 in reported general payments places this provider in the 90th percentile of 69 neurology with special qualifications in child neurology providers in New Jersey.
See all neurology with special qualifications in child neurology providers in New Jersey →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EpidiolexCannabidiol (Cbd) | 29 | $94,358 |
| ValtocoDiazepam | 31 | $31,781 |
| FycompaPerampanel | 19 | $28,770 |
| Clobazam | 56 | $11,206 |
| Lamotrigine OdtLamotrigine | 11 | $3,423 |
| Zonisamide | 23 | $996 |
| Levetiracetam | 33 | $836 |
| Lacosamide | 28 | $824 |
| Divalproex Sodium ErDivalproex Sodium | 20 | $443 |
| Divalproex Sodium | 19 | $365 |
| Quetiapine Fumarate | 15 | $298 |
| Aripiprazole | 15 | $245 |
| Clonazepam | 14 | $66 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurelis, Inc.Valtoco | $340 | $31,78131 claims |
| Eisai Inc.Fycompa | $41 | $28,77019 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 69 neurology with special qualifications in child neurology providers in New Jersey.
Other neurology with special qualifications in child neurology in New Brunswick
- Rajeshwari MahalinghamNew Brunswick$3K
- Vikram BhiseNew Brunswick$3K
- Janti ChaabanNew Brunswick$495
- Chandrabhaga MiskinNew Brunswick$392
- Anu VenkatNew Brunswick$235
- Andrea RichardsNew Brunswick$180
- Stephanie EnnerNew Brunswick$137
- Amanda SpinnerNew Brunswick$81
- Juliann PaolicchiHackensack$80K
- Trevor DesouzaMorristown$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.